Works matching IS 21576564 AND DT 2023 AND VI 12 AND IP 2

Results: 6

Combining Cell Technologies With Biomimetic Tissue Engineering Applications: A New Paradigm for Translational Cardiovascular Therapies.
Published in:
Stem Cells Translational Medicine, 2023, v. 12, n. 2, p. 72, doi. 10.1093/stcltm/szad002
By:
- Motta, Sarah E;
- Martin, Marcy;
- Gähwiler, Eric K N;
- Visser, Valery L;
- Zaytseva, Polina;
- Ehterami, Arian;
- Hoerstrup, Simon P;
- Emmert, Maximilian Y
Publication type:
Article
Characterization of Intestinal Mesenchymal Stromal Cells From Patients With Inflammatory Bowel Disease for Autologous Cell Therapy.
Published in:
Stem Cells Translational Medicine, 2023, v. 12, n. 2, p. 112, doi. 10.1093/stcltm/szad003
By:
- Anbazhagan, Murugadas;
- Geem, Duke;
- Venkateswaran, Suresh;
- Pelia, Ranjit;
- Kolachala, Vasantha L;
- Dodd, Anne;
- Maddipatla, Sushma C;
- Cutler, David J;
- Matthews, Jason D;
- Chinnadurai, Raghavan;
- Kugathasan, Subra
Publication type:
Article
Rehabilitative Training Enhances Therapeutic Effect of Human-iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury.
Published in:
Stem Cells Translational Medicine, 2023, v. 12, n. 2, p. 83, doi. 10.1093/stcltm/szac089
By:
- Shibata, Takahiro;
- Tashiro, Syoichi;
- Shibata, Shinsuke;
- Shinozaki, Munehisa;
- Shindo, Tomoko;
- Hashimoto, Shogo;
- Kawai, Momotaro;
- Kitagawa, Takahiro;
- Ago, Kentaro;
- Matsumoto, Morio;
- Nakamura, Masaya;
- Okano, Hideyuki;
- Nagoshi, Narihito
Publication type:
Article
Prophylactic Administration of Mesenchymal Stromal Cells Does Not Prevent Arrested Lung Development in Extremely Premature-Born Non-Human Primates.
Published in:
Stem Cells Translational Medicine, 2023, v. 12, n. 2, p. 97, doi. 10.1093/stcltm/szac088
By:
- Möbius, Marius A;
- Seidner, Steven R;
- McCurnin, Donald C;
- Menschner, Leonhard;
- Fürböter-Behnert, Isabel;
- Schönfeld, Julia;
- Marzahn, Jenny;
- Freund, Daniel;
- Münch, Nadine;
- Hering, Sandra;
- Mustafa, Shamimunisa B;
- Anzueto, Diana G;
- Winter, Lauryn A;
- Blanco, Cynthia L;
- Hanes, Martha A;
- Rüdiger, Mario;
- Thébaud, Bernard
Publication type:
Article
Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future.
Published in:
Stem Cells Translational Medicine, 2023, v. 12, n. 2, p. 55, doi. 10.1093/stcltm/szac086
By:
- Sanchez-Petitto, Gabriela;
- Rezvani, Katayoun;
- Daher, May;
- Rafei, Hind;
- Kebriaei, Partow;
- Shpall, Elizabeth J;
- Olson, Amanda
Publication type:
Article
Correction to: Pluripotent Stem Cell-Based Screening Identifies CUDC-907 as an Effective Compound for Restoring the In Vitro Phenotype of Nakajo-Nishimura Syndrome.
Published in:
Stem Cells Translational Medicine, 2023, v. 12, n. 2, p. 123, doi. 10.1093/stcltm/szac085
Publication type:
Article

Works matching IS 21576564 AND DT 2023 AND VI 12 AND IP 2

Combining Cell Technologies With Biomimetic Tissue Engineering Applications: A New Paradigm for Translational Cardiovascular Therapies.

Characterization of Intestinal Mesenchymal Stromal Cells From Patients With Inflammatory Bowel Disease for Autologous Cell Therapy.

Rehabilitative Training Enhances Therapeutic Effect of Human-iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury.

Prophylactic Administration of Mesenchymal Stromal Cells Does Not Prevent Arrested Lung Development in Extremely Premature-Born Non-Human Primates.

Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future.

Correction to: Pluripotent Stem Cell-Based Screening Identifies CUDC-907 as an Effective Compound for Restoring the In Vitro Phenotype of Nakajo-Nishimura Syndrome.